Results 131 to 140 of about 594,306 (305)

A Qualitative Analysis of Patient Perspectives and Preferences in Lupus Management to Guide Lupus Guidelines Development

Arthritis Care &Research, EarlyView.
Objective A patient‐centered approach for chronic disease management, including systemic lupus erythematosus (SLE), aligns treatment with patients’ values and preferences, leading to improved outcomes. This paper summarizes how patient experiences, perspectives, and priorities informed the American College of Rheumatology (ACR) 2024 Lupus Nephritis (LN)
Shivani Garg, Izzy Hartel, Lisa R. Sammaritano, Anca Askanase, Bonnie L. Bermas, Maria Dall'Era, Alí Duarte‐García, Victoria P. Werth, Brad Rovin, Reem A. Mustafa, Amy S. Turner, Bené Williams, Brian L. Ung, Hiya Bhavsar, Monique C. Gore‐Massy, Nahirannette Pulido, Natacha Guerrero, Natalie M. Smith, Wambui Machua, Linda T. Hiraki, Mary Beth Son   +20 more
wiley   +1 more source

Our work, our stories, 2011-2012 [PDF]

National Center for Emerging and Zoonotic Infectious Diseases: Our Work, Our Stories 2011-2012 serves several purposes. First, it highlights major accomplishments from fiscal years 2011 and 2012 (October 1, 2010-September 30, 2012).
National Center for Emerging and Zoonotic Infectious Diseases (U.S.)
core  

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients With Systemic Lupus Erythematosus: A Multicenter, Open‐Label Trial

Arthritis Care &Research, EarlyView.
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; ClinicalTrials.gov identifier ...
Hermine I. Brunner, Jordi Antón, Inmaculada Calvo‐Penadés, Richard Dimelow, Gerd Horneff, Sylvia Kamphuis, Rebecca Marino, Andre van Maurik, Kirsten Minden, Masaaki Mori, Josephine Ocran‐Appiah, Christel Wilkinson, Yuichi Yamasaki, Deepak Assudani, for the Pediatric Rheumatology Collaborative Study Group (PRCSG) and Paediatric Rheumatology International Trials Organisation (PRINTO) Network investigators   +14 more
wiley   +1 more source

Patterns of genomic deletions in monkeypox virus during the 2022 outbreak in the United States

Nature Communications
Poxviruses have a low overall rate of point mutations but are known to exhibit genomic duplications and deletions that can influence viral evolution.
Crystal M. Gigante, Daisy McGrath, Sophia Sukkestad, Hui Zhao, Mengfei Peng, Jade Takakuwa, Kimberly Wilkins, Vaughn Wicker, Audrey Matheny, Theodora Khan, Whitni B. Davidson, Mili Sheth, Alex Burgin, Julie Hand, Gillian Richardson, Danielle Haydel, Mark Burroughs, Jasmine Padilla, Justin S. Lee, Dhwani Batra, Ethan E. Hetrick, Dakota T. Howard, Kyle O’Connell, Jessica L. Rowell, Shatavia Morrison, Sarah Gillani, Michelle Lee, Anil Mangla, David Blythe, Robert Myers, Lynsey Kovar, Matthew H. Seabolt, Michael R. Weigand, Panayampalli S. Satheshkumar, Andrea M. McCollum, Christina L. Hutson, Yu Li   +36 more
doaj   +1 more source

Managing the health risks associated with agriculture: An overview of research by the International Livestock Research Institute [PDF]

, 2014
Over 60 per cent of the newly identified infectious diseases that have affected people over the past few decades have been caused by pathogens originating from animals or animal products. In agricultural areas that use more water, people face increased
Grace, Delia, Lore, Tezira A.
core  

Immune Checkpoint Inhibitor Related Myositis and Associated Triad Overlap Syndrome

Arthritis Care &Research, Accepted Article.
Objective Immune checkpoint inhibitor (ICI) myositis is a rare but highly morbid condition, particularly with the ICI myositis triad syndrome of myositis, myocarditis, and myasthenia gravis. We report the clinical characteristics of ICI myositis and all‐cause mortality in these patients.
Selene Rubino, Grant W Cannon, Brian C Sauer, Jorge Rojas, Gregory J Stoddard, Gary A Kunkel, Jessica A. Walsh, Bryant R England, Joshua F Baker, Tawnie J Braaten   +9 more
wiley   +1 more source

Studi Deskriptif Kemampuan Laboratorium Emerging Infectious Diseases di Indonesia Tahun 2004 [PDF]

, 2007
Kewaspadaan dini terhadap peningkatan kasus new emerging dan re-emerging diseases pada dasarnya tidak terlepas dari kesiapan laboratorium sebagai perangkat pendukung diagnosis.
Anorital, A. (Anorital), Dewi, R. M. (Rita), Harun, S. (Syahrial), Heriyanto, B. (Bambang), Suwandono, A. (Agus)   +4 more
core  

Lipid Nanoparticles for the Delivery of CRISPR/Cas9 Machinery to Enable Site‐Specific Integration of CFTR and Mutation‐Agnostic Disease Rescue

Advanced Functional Materials, EarlyView.
Lipid nanoparticles (LNPs) are optimized to co‐deliver Cas9‐encoding messenger RNA (mRNA), a single guide RNA (sgRNA) targeting the endogenous cystic fibrosis transmembrane conductance regulator (CFTR) gene, and homologous linear double‐stranded donor DNA (ldsDNA) templates encoding CFTR.
Ruth A. Foley, Paul G. Ayoub, Vrishti Sinha, Colin Juett, Alicia Sanoyca, Emily C. Duggan, Lindsay E. Lathrop, Priyanka Bhatt, Kevin Coote, Beate Illek, Brigitte N. Gomperts, Donald B. Kohn, Steven J. Jonas   +12 more
wiley   +1 more source

Combinatorial Synthesis of Next Generation Water‐Soluble Quaternized N‐Halamine Oligomers with Long‐Lasting Antiviral Properties

Advanced Functional Materials, EarlyView.
A combinatorial library of dual‐functional antiviral oligomers incorporating N‐halamine and quaternary ammonium functionalities is developed for long‐lasting antiviral activity. The lead materials exhibit rapid and durable antiviral activity against SARS‐CoV‐2 variants and influenza H1N1, with 4 to 5 log reduction in viral copies at 5 mg mL−1 ...
Eid Nassar‐Marjiya, Konda Reddy Kunduru, Krishanu Ghosal, Luna Rizik, Nofar Atari, Mahran Daifa, Neta Kutner, Bassma Khamaisi, Qi Wu, Simran Jindal, Merna Shaheen‐Mualim, Ranabir Majumder, Mahitosh Mandal, Michal Mandelboim, Shady Farah   +14 more
wiley   +1 more source

Strategic plan 2012-2017 [PDF]

The National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) was established in 2010, with a mission and scientific activities that trace back to the earliest days of the Centers for Disease Control and Prevention (CDC).
National Center for Emerging and Zoonotic Infectious Diseases (U.S.)
core